iTeos Therapeutics, Inc. (ITOS)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

139 MAIN STREET CAMBRIDGE, MA 02142

iTeos Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company discovers and develops immuno-oncology therapeutics for treatment of patients. iTeos Therapeutics serves customers in the United States and Belgium.

Data as of 2021-02-27 11:33:00 -0500
Market Cap1.457 Billion Shares Outstanding35.045 Million Avg 30-day Volume239.414 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-22.31 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low43.69 / 17.5 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from ITOS instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 4 3 33.33% 3 (0.18%) 2 (0.12%) 50.0%
Funds Holding: 71 54 31.48% 26 (1.57%) 18 (1.12%) 44.44%
13F shares: 26.891 Million 24.903 Million 7.98% 15.844 Million 15.379 Million 3.02%
% Ownership 76.7324 71.0596 7.98% 45.2102 43.885 3.02%
New Positions: 21 53 -60.38% 8 18 -55.56%
Increased Positions 24 6
Closed Positions 4
Reduced Positions 12 6
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ITOS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ITOS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GALL MATTHEW CHIEF FINANCIAL OFFICER

  • Officer
72,000 2021-03-01 1

MCGRATH YVONNE VP, RESEARCH AND DEVELOPMENT

  • Officer
45,000 2021-03-01 1

CALL MATTHEW CHIEF OPERATING OFFICER

  • Officer
72,000 2021-03-01 1

LAGER JOANNE JENKINS CHIEF MEDICAL OFFICER

  • Officer
122,000 2021-03-01 1

DETHEUX MICHEL CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
144,000 2021-03-01 1

RODEN MATTHEW

  • Director
0 2020-11-09 2

BOXER CAPITAL, LLC

BOXER ASSET MANAGEMENT INC.

LEWIS JOSEPH

MVA INVESTORS, LLC

  • 10% Owner
72,243 2020-07-28 1

MPM BIOVENTURES 2014, L.P.

EVNIN LUKE

FOLEY TODD

MPM BIOVENTURES 2014 (B), L.P.

MPM ASSET MANAGEMENT INVESTORS BV2014 LLC

MPM BIOVENTURES 2014 LLC

MPM BIOVENTURES 2014 GP LLC

MPM BIOVENTURES 2018, L.P.

MPM BIOVENTURES 2018 (B), L.P.

MPM ASSET MANAGEMENT INVESTORS BV2018 LLC

  • 10% Owner
9,510,692 2020-07-28 1

RA CAPITAL MANAGEMENT, L.P.

KOLCHINSKY PETER

SHAH RAJEEV M.

  • 10% Owner
4,417,259 2020-07-28 1

MPM BIOVENTURES 2014, L.P.

MPM BIOVENTURES 2018 LLC

MPM BIOVENTURES 2018 GP LLC

  • 10% Owner
9,510,692 2020-07-28 1

GADICKE ANSBERT

UBS ONCOLOGY IMPACT FUND L.P.

MPM ONCOLOGY IMPACT MANAGEMENT GP LLC

MPM ONCOLOGY IMPACT MANAGEMENT LP

ONCOLOGY IMPACT FUND (CAYMAN) MANAGEMENT L.P.

  • Director
  • 10% Owner
  • X*X*X*X*
15,459,380 2020-07-28 2

DAVIS AARON I.

  • Director
  • 10% Owner
7,409,518 2020-07-28 2

DIROCCO DEREK

  • Director
0 2020-07-23 1

HALLAL DAVID

  • Director
0 2020-07-23 1

GADICKE ANSBERT

  • Director
  • 10% Owner
0 2020-07-23 2

RHOADS ANN D

  • Director
0 2020-07-23 1

BINISZKIEWICZ DETLEV

  • Director
0 2020-07-23 1

VAN HAUWERMEIREN TIMOTHY

  • Director
0 2020-07-23 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

GALL MATTHEW - Officer CHIEF FINANCIAL OFFICER

2021-03-03 16:15:40 -0500 2021-03-01 A 72,000 a 72,000 direct

CALL MATTHEW - Officer CHIEF OPERATING OFFICER

2021-03-03 16:15:26 -0500 2021-03-01 A 72,000 a 72,000 direct

DETHEUX MICHEL - Director - Officer CHIEF EXECUTIVE OFFICER

2021-03-03 16:16:27 -0500 2021-03-01 A 144,000 a 144,000 direct

MCGRATH YVONNE - Officer VP, RESEARCH AND DEVELOPMENT

2021-03-03 16:15:35 -0500 2021-03-01 A 45,000 a 45,000 direct

LAGER JOANNE JENKINS - Officer CHIEF MEDICAL OFFICER

2021-03-03 16:15:24 -0500 2021-03-01 A 122,000 a 122,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ITEOS THERAPEUTICS INC ITOS 2021-03-03 21:15:03 UTC -0.3598 0.4298 30000
ITEOS THERAPEUTICS INC ITOS 2021-03-03 20:45:03 UTC -0.3598 0.4298 30000
ITEOS THERAPEUTICS INC ITOS 2021-03-03 20:15:03 UTC -0.3598 0.4298 30000
ITEOS THERAPEUTICS INC ITOS 2021-03-03 19:45:03 UTC -0.3598 0.4298 30000
ITEOS THERAPEUTICS INC ITOS 2021-03-03 19:15:02 UTC -0.3598 0.4298 30000
ITEOS THERAPEUTICS INC ITOS 2021-03-03 18:45:03 UTC -0.3598 0.4298 30000
ITEOS THERAPEUTICS INC ITOS 2021-03-03 18:15:04 UTC -0.3598 0.4298 30000
ITEOS THERAPEUTICS INC ITOS 2021-03-03 17:45:02 UTC -0.3598 0.4298 30000
ITEOS THERAPEUTICS INC ITOS 2021-03-03 17:15:03 UTC -0.3598 0.4298 30000
ITEOS THERAPEUTICS INC ITOS 2021-03-03 16:45:03 UTC -0.3598 0.4298 30000
ITEOS THERAPEUTICS INC ITOS 2021-03-03 16:15:04 UTC -0.3598 0.4298 30000
ITEOS THERAPEUTICS INC ITOS 2021-03-03 15:45:03 UTC -0.3598 0.4298 30000
ITEOS THERAPEUTICS INC ITOS 2021-03-03 15:15:03 UTC -0.3598 0.4298 30000
ITEOS THERAPEUTICS INC ITOS 2021-03-03 14:45:03 UTC -0.3598 0.4298 30000
ITEOS THERAPEUTICS INC ITOS 2021-03-03 14:15:03 UTC -0.3598 0.4298 30000
ITEOS THERAPEUTICS INC ITOS 2021-03-03 13:45:03 UTC -0.3598 0.4298 30000
ITEOS THERAPEUTICS INC ITOS 2021-03-03 13:15:04 UTC -0.3598 0.4298 30000
ITEOS THERAPEUTICS INC ITOS 2021-03-03 12:45:03 UTC -0.3598 0.4298 8000
ITEOS THERAPEUTICS INC ITOS 2021-03-02 22:15:02 UTC -0.3598 0.4298 25000
ITEOS THERAPEUTICS INC ITOS 2021-03-02 21:45:03 UTC -0.3598 0.4298 25000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments